A carregar...
Emerging Immunotherapy for Acute Myeloid Leukemia
Several immune checkpoint molecules and immune targets in leukemic cells have been investigated. Recent studies have suggested the potential clinical benefits of immuno-oncology (IO) therapy against acute myeloid leukemia (AML), especially targeting CD33, CD123, and CLL-1, as well as immune checkpoi...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7920435/ https://ncbi.nlm.nih.gov/pubmed/33669431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041944 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|